Clinical Trials on Extent IV Thoracoabdominal in Switzerland

Total 58 results

University Hospital, Geneva
Ligue Pulmonaire Genevoise

Completed

Use of a Gamma-IFN Assay in Contact Tracing for Tuberculosis in a Low-Incidence, High Immigration Area

Tuberculosis | Latent Tuberculosis Infection

Switzerland
Ligue Pulmonaire Genevoise

Completed

Interferon Gamma Release Assays (IGRA) Testing Versus Tuberculin Skin Test in Renal Transplant Recipients

Latent Tuberculosis Infection

Switzerland
University of Zurich

Recruiting

Safety and Tolerability of Chlorquine in Addition to Anti-tuberculosis Therapy

Tuberculosis Infection

Switzerland
Cantonal Hospital of St. Gallen

Completed

Reduction of Stent Associated Morbidity by Minimizing Stent Material.

Ureteral Stent Related Morbidity

Switzerland
Cantonal Hospital of St. Gallen

Completed

Assessment of Longterm Ureteral Stenting

Longterm Indwelling Ureteral Stent

Switzerland
University Hospital Inselspital, Berne
GE Healthcare

Completed

ERPS, BIS and Entropy for Neuromonitoring in ICU Patients

Electroencephalography | Deep Sedation | Event-Related Potentials | Evoked Potentials, Auditory

Switzerland
Stentys

Unknown

Registry to Assess the STENTYS Xposition S for Revascularization of Coronary Arteries In Routine cliNical Practice (WIN)

Coronary Self Expanding Stent

Netherlands, Switzerland
BioGene Pharmaceutical Ltd.

Withdrawn

Safety, Tolerability and Efficacy of Vaginal Suppositories for Treatment of the Endometriosis (ELTA)

Endometriosis | Endometriosis Ovary | Endometriosis, Rectum | Endometriosis Externa

Switzerland
Lifetech Scientific (Shenzhen) Co., Ltd.
Medtronic

Completed

Lifetech CeraFlex™ Post-Market Surveillance Study

Atrial Septal Defect | Patent Foramen Ovale | Patent Ductus Arteriosus

Germany, Switzerland, France, Ireland, Italy
University Hospital, Geneva
European Society for Blood and Marrow Transplantation

Recruiting

Polymorphisms and Busulfan Pharmacokinetic Study

Children Who Receive a Stem Cell Transplantation With Busulfan IV

Canada, France, Switzerland
University Hospital, Basel, Switzerland

Completed

Glycosylated Hemoglobin and Risk of Perioperative Major Cardiovascular Events in Diabetic Patients Undergoing Coronary Bypass Revascularization (HbA1c)

Diabetes Mellitus | Coronary Artery Bypass Graft | Cardiovascular Event

Switzerland
University Hospital, Geneva
Ligue Pulmonaire Genevoise

Completed

Detection of Latent Tuberculosis in Hemodialysis Patients

Chronic Renal Failure

Switzerland
University Hospital, Geneva
Geneva University, School of medicine

Completed

Assessing Parathyroid Glands Vascularisation by ICG Fluoroscopy

Parathyroid Function Low Adverse Event

Switzerland
University of Zurich

Completed

Monocentric Pilot Study Investigating the Metabolic Activity of Melanoma in Vivo During Sorafenib and Dacarbazine

Melanoma Stage III or IV | No Prior Chemotherapy

Switzerland
University Hospital Inselspital, Berne

Completed

Impact Of Closure Of Patent Foramen Ovale On Apnoea-Hypopnoea-Index, Nocturnal Hypoxemia And Systemic Vascular Function In Patients With Obstructive Sleep Apnoea

Obstructive Sleep Apnea

Switzerland
Kurt Hersberger

Terminated

Multidrug Blister Pack Study

Any Event Leading to Hospitalisation

Switzerland
Foundation for Cardiovascular Research, Zurich
Abbott Medical Devices

Unknown

PC-Trial: Patent Foramen Ovale and Cryptogenic Embolism

Heart Septal Defects, Atrial | Embolism, Paradoxical

Australia, Austria, Belgium, Switzerland
University of Leipzig
German Research Foundation; Baylor College of Medicine; University of Pennsylvania and other collaborators

Active, not recruiting

Paraplegia Prevention in Aortic Aneurysm Repair by Thoracoabdominal Staging (PAPAartis)

Aortic Aneurysm, Thoracoabdominal

Sweden, Netherlands, Germany, France, Poland, Switzerland, Austria, United Kingdom, Italy
University of Zurich

Recruiting

Intrathecal Double Checkpoint Inhibition (IT-IO)

Melanoma Stage IV | Leptomeningeal Metastasis | Non-small Cell Lung Cancer Stage IV

Switzerland
Oncology Institute of Southern Switzerland
Ente Ospedaliero Cantonale, Bellinzona; Clinical Trial Unit Ente Ospedaliero... and other collaborators

Active, not recruiting

Atezolizumab Plus 8 Gy Single-fraction Radiotherapy for Advanced Oligoprogressive NSCLC

NSCLC Stage IV

Switzerland
Luzerner Kantonsspital

Recruiting

The Value of IVL Compared To OPN Non-Compliant Balloons for Treatment of RefractorY Coronary Lesions (VICTORY) Trial (VICTORY)

Coronary Artery Disease | Coronary Disease | Coronary Artery Calcification | Stent Restenosis | Calcific Coronary Arteriosclerosis

Switzerland
University Hospital, Clermont-Ferrand
Abbott; Corelab ISIT

Completed

Morphological Parameters of In-stent RESTenosis Assessed and Identified by OCT (RESTO)

In-stent Restenosis

France, Belgium, Switzerland
University Hospital, Geneva

Unknown

Prospective Clinical Follow-up After the Percutaneous Closure of a Patent Foramen Ovale (PFO-HUG)

Stroke | Foramen Ovale, Patent

Switzerland
University Hospital, Basel, Switzerland
Stiftung für Krebskranke Kinder

Completed

Study to Evaluate Blood and Urine Kidney Injury Markers to Facilitate Early Detection of Renal Adverse Drug Events in Pediatric Cancer Patients Treated With Nephrotoxic Chemotherapy (Kid-MaCareOnco)

Kidney Impairment

Switzerland
University Hospital, Basel, Switzerland

Completed

Effects of FXR Activation on Hepatic Lipid and Glucose Metabolism

Metabolic Syndrome | Familial Combined Hyperlipidemia | Familial Hypertriglyceridemia

Switzerland
University of Zurich
Medical University of Vienna; RWTH Aachen University; University Hospital Heidelberg and other collaborators

Terminated

Aspirin® Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis in Patients With PTS (ARIVA)

Stent Stenosis | Venous Thromboses

Austria, Germany, Switzerland
Luzerner Kantonsspital

Recruiting

SIROOP Registry - A Prospective Registry Study to Evaluate the Outcomes of Coronary Artery Disease Patients Treated With SIROlimus Or Paclitaxel Eluting Balloon Catheters (SIROOP)

Coronary Artery Disease | Coronary Disease | Angina, Stable | Angina Pectoris | Coronary Arteriosclerosis | Angina, Unstable | Coronary Artery Calcification | Stent Thrombosis | Coronary Restenosis | Stable Chronic Angina

Switzerland
ETOP IBCSG Partners Foundation
AstraZeneca

Active, not recruiting

Osimertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR Mutant NSCLC (STEREO) (STEREO)

NSCLC Stage IV | EGFR Gene Mutation

Singapore, Sweden, Korea, Republic of, Spain, Switzerland, Netherlands, Italy, Poland
Luzerner Kantonsspital

Recruiting

COMPLEX Registry - A Prospective COhort Study to Describe the Management and Outcomes of Patients Presenting With compLEX and Calcified Coronary Artery Disease (COMPLEX)

Coronary Artery Disease | Coronary Disease | Angina, Stable | Angina Pectoris | Coronary Arteriosclerosis | Angina, Unstable | Coronary Artery Calcification | Stent Thrombosis | Coronary Restenosis | Stable Chronic Angina

Switzerland
Biosensors Europe SA
European Cardiovascular Research Center

Completed

Leaders Free III: BioFreedom™ Clinical Trial

Myocardial Infarction | Mortality | Bleeding | Cardiac Death | Stent Thrombosis

France, Switzerland
Biosensors Europe SA
European Cardiovascular Research Center

Unknown

A Randomized Clinical Evaluation of the BioFreedom™ Stent (Leaders Free)

Bleeding | Stable Angina | In-stent Coronary Artery Restenosis | Ischemic Heart Disease Silent | ST Elevation (STEMI) and Non-ST Elevation (NSTEMI) Myocardial Infarction

Switzerland
Swiss Group for Clinical Cancer Research

Recruiting

Trial Comparing Systemic Therapy Alone and With Local Ablative Treatment for Stage IV NSCL Cancer Patients (salVage)

Non-small Cell Lung Cancer (NSCLC) | Stage IV

Switzerland
Société des Produits Nestlé (SPN)
Waldkrankenhaus Protestant Hospital, Spandau; Kinderarztpraxis Köllges, Mossakowski... and other collaborators

Completed

Human Milk Oligosaccharides (HMOs) Post-market Study on Infants (NEHMO) (NeHMO DACH)

Growth | Tolerance | Adverse Event | Disorder of Intestine | Formula Satisfaction

Austria, Germany, Switzerland
Dr Jean Yannis PERENTES

Recruiting

Treatment Pleural Carcinosis of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin Administration (PITHAC)

Carcinoma, Non-Small-Cell Lung | Gastric Cancer | Esophageal Cancer | Ovarian Cancer | Mesothelioma, Malignant | Carcinoma Breast Stage IV

Switzerland
Raban Jeger

Recruiting

Atrial Fibrillation Before and After Patent Foramen Ovale Closure Study (ALFA ROMEO)

Atrial Fibrillation | Foramen Ovale, Patent | Cryptogenic Stroke

Switzerland
Swiss Group for Clinical Cancer Research

Active, not recruiting

1st Line Durvalumab in PS 2 NSCLC Patients

NSCLC Stage IV | NSCLC Stage IIIB

Switzerland
Amal Therapeutics
Boehringer Ingelheim

Active, not recruiting

Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer (KISIMA-01)

Metastatic Colorectal Cancer | Colorectal Cancer | Liver Metastasis Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal Cancer | MSS

United States, Belgium, Switzerland, Germany
Abbott Medical Devices

Recruiting

Trevisio Post-Approval Study (TrevisioPAS)

PFO - Patent Foramen Ovale | VSD - Muscular Ventricular Septal Defect | PIVSD - Post Infarct Muscular Ventricular Septal Defect | ASD - Atrial Septal Defect

Spain, Germany, Poland, France, Italy, Netherlands, Switzerland
Abbott Medical Devices

Terminated

PRIMA PFO Migraine Trial (PRIMA)

Migraine | Patent Foramen Ovale | Migraine With Aura | PFO

United Kingdom, Germany, Canada, Switzerland
ETOP IBCSG Partners Foundation
AstraZeneca

Recruiting

Immunotherapy, Chemotherapy, Radiotherapy and Surgery for Synchronous Oligo-metastatic NSCLC (CHESS)

Non-small Cell Lung Cancer | Oligometastasis | Stage IV

Switzerland, Netherlands, Spain, Italy
Abbott Medical Devices

Recruiting

AMPLATZER PFO Occluder Post Approval Study (PFO PAS)

Stroke | Patent Foramen Ovale

United States, Germany, Canada, Switzerland, Italy, Portugal, United Kingdom
ETOP IBCSG Partners Foundation
Roche Pharma AG

Active, not recruiting

ABC-lung: Atezolizumab, Bevacizumab and Chemotherapy in EGFR-mutant Non-small Cell Lung Carcinoma (ABC-lung)

EGFRmutant Stage IIIB/C or IV Non-squamous NSCLC

Singapore, Spain, Korea, Republic of, Switzerland, Germany
Pierre Fabre Pharma GmbH
Pierre Fabre Pharma Austria; Pierre Fabre Pharma AG

Recruiting

Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment (BERING)

Melanoma Stage IV | Melanoma Stage III

Austria, Germany, Switzerland
MicroPort CRM
Sorin CRM

Unknown

Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the PARADYM RF SonR CRT-D (RESPOND-CRT)

Heart Failure NYHA Class III and Ambulatory IV

United States, Spain, United Kingdom, Germany, Italy, Australia, Netherlands, Portugal, France, Austria, Switzerland, Slovenia
OncoSec Medical Incorporated
Merck Sharp & Dohme LLC

Active, not recruiting

Tavo and Pembrolizumab in Patients With Stage III/IV Melanoma Progressing on Either Pembrolizumab or Nivolumab Treatment (Keynote-695)

Stage III/IV Melanoma

United States, Australia, Canada, Italy, Switzerland
Institut National de la Santé Et de la Recherche...
UPCET; PARTNERS for International clinical Research; European Fundation for the... and other collaborators

Active, not recruiting

Prophylactic Treatment of the Ductus Arteriosus in Preterm Infants by Acetaminophen (TREOCAPA)

Acetaminophen | Patency of the Ductus Arteriosus | Extreme Prematurity

France, Norway, Belgium, Estonia, Ireland, Switzerland, Sweden, Denmark, Finland, Hungary, Italy, Portugal
Jasper Gerritsen
Massachusetts General Hospital; Universitaire Ziekenhuizen KU Leuven; University... and other collaborators

Recruiting

The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201) (SUPRAMAX)

Glioblastoma | Brain Neoplasms | Astrocytoma, Grade III | High-grade Glioma | Astrocytoma, Grade IV | Glioblastoma, IDH-mutant | Glioblastoma, IDH-wildtype | Glioblastoma Multiforme, Adult | Brain Neoplasm, Primary | Brain Neoplasm, Malignant | Astrocytoma, Malignant | Brain Neoplasms, Adult

United States, Germany, Belgium, Switzerland, Netherlands
NRG Oncology
National Cancer Institute (NCI)

Completed

Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer

Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | Prostate Adenocarcinoma | Stage IV Breast Cancer | Recurrent Breast Carcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Male Breast Carcinoma

United States, Canada, Switzerland
Abbott Medical Devices

Completed

XIENCE V: SPIRIT WOMEN Sub-study

Myocardial Ischemia | Coronary Artery Disease | Coronary Arteriosclerosis | Stent Thrombosis | Vascular Disease | Coronary Artery Stenosis | Total Coronary Occlusion | Coronary Artery Restenosis

Italy, Norway, Switzerland, Denmark, Spain, Poland, Belgium, Argentina, Austria, Brazil, France, Germany, Hungary, Latvia, Netherlands
ETOP IBCSG Partners Foundation
European Organisation for Research and Treatment of Cancer - EORTC; Amgen

Terminated

Survival imProvement in Lung cancEr iNduced by DenOsUmab theRapy (SPLENDOUR)

Lung Cancer Non-small Cell Stage IV

Ireland, Spain, Switzerland, United Kingdom, France, Austria, Slovenia, Belgium, Italy, Germany, Poland

Clinical Trials on Extent IV Thoracoabdominal in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations